Find details from the first study to forecast the multidimensional impact of chronic kidney disease, a study highlighting the widespread prevalence of cardiovascular-kidney-metabolic syndrome in the US, and more.
The latest issue of the Patient Care Online digital edition is now live. The digital edition is available monthly and offer a selection of the website's top ranked news and features, as measured by Patient Care reader interest and engagement.
This month's issue focuses on cardiovascular-kidney-metabolic (CKM) health, including findings from a study that examined the widespread prevalence of CKM syndrome among US adults, details from the first study to forecast the multidimensional impact of chronic kidney disease over a 10-year horizon, and data from an interim analysis of the phase 2 proof-of-concept LEGEND trial that showed lanifibranor plus empagliflozin is effective in patients with type 2 diabetes and metabolic dysfunction–associated steatohepatitis.
Find out more in the digital edition, here.